Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. more
Time Frame | NVAX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 6.27% | -1.8% | -0.77% |
1-Month Return | -2.11% | -3.48% | 0.71% |
3-Month Return | -28.23% | -7.2% | 8.81% |
6-Month Return | -47.26% | -1.54% | 12.32% |
1-Year Return | 58.49% | 8.39% | 30.57% |
3-Year Return | -94.78% | 6.07% | 29.21% |
5-Year Return | 115.65% | 44.07% | 91.95% |
10-Year Return | -92.56% | 106.3% | 196.04% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 18.66M | 475.60M | 1.15B | 1.60B | 983.71M | [{"date":"2019-12-31","value":1.17,"profit":true},{"date":"2020-12-31","value":29.74,"profit":true},{"date":"2021-12-31","value":71.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":61.52,"profit":true}] |
Cost of Revenue | 113.84M | 747.03M | 12.66M | 902.64M | 343.77M | [{"date":"2019-12-31","value":12.61,"profit":true},{"date":"2020-12-31","value":82.76,"profit":true},{"date":"2021-12-31","value":1.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":38.08,"profit":true}] |
Gross Profit | (95.18M) | 475.60M | 1.15B | 696.31M | 639.94M | [{"date":"2019-12-31","value":-8.3,"profit":false},{"date":"2020-12-31","value":41.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":60.74,"profit":true},{"date":"2023-12-31","value":55.83,"profit":true}] |
Gross Margin | (510.02%) | 100.00% | 100.00% | 43.55% | 65.05% | [{"date":"2019-12-31","value":-510.02,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":43.55,"profit":true},{"date":"2023-12-31","value":65.05,"profit":true}] |
Operating Expenses | 148.26M | 892.32M | 2.83B | 1.34B | 779.13M | [{"date":"2019-12-31","value":5.23,"profit":true},{"date":"2020-12-31","value":31.5,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":47.34,"profit":true},{"date":"2023-12-31","value":27.5,"profit":true}] |
Operating Income | (120.58M) | (416.72M) | (1.69B) | (644.74M) | (566.51M) | [{"date":"2019-12-31","value":-12058100000,"profit":false},{"date":"2020-12-31","value":-41671900000,"profit":false},{"date":"2021-12-31","value":-168657600000,"profit":false},{"date":"2022-12-31","value":-64473600000,"profit":false},{"date":"2023-12-31","value":-56651100000,"profit":false}] |
Total Non-Operating Income/Expense | (25.73M) | (16.68M) | (49.09M) | (28.79M) | 8.58M | [{"date":"2019-12-31","value":-299.83,"profit":false},{"date":"2020-12-31","value":-194.46,"profit":false},{"date":"2021-12-31","value":-572.11,"profit":false},{"date":"2022-12-31","value":-335.56,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (132.69M) | (418.26M) | (1.71B) | (653.65M) | (543.03M) | [{"date":"2019-12-31","value":-13269400000,"profit":false},{"date":"2020-12-31","value":-41825900000,"profit":false},{"date":"2021-12-31","value":-171453600000,"profit":false},{"date":"2022-12-31","value":-65364700000,"profit":false},{"date":"2023-12-31","value":-54303100000,"profit":false}] |
Income Taxes | (2.59M) | 9.25M | 29.21M | 4.29M | 2.03M | [{"date":"2019-12-31","value":-8.87,"profit":false},{"date":"2020-12-31","value":31.65,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":14.69,"profit":true},{"date":"2023-12-31","value":6.95,"profit":true}] |
Income After Taxes | (130.10M) | (427.50M) | (1.74B) | (657.94M) | (545.06M) | [{"date":"2019-12-31","value":-13010200000,"profit":false},{"date":"2020-12-31","value":-42750500000,"profit":false},{"date":"2021-12-31","value":-174375100000,"profit":false},{"date":"2022-12-31","value":-65793900000,"profit":false},{"date":"2023-12-31","value":-54506200000,"profit":false}] |
Income From Continuous Operations | (132.69M) | (418.26M) | (1.74B) | (657.94M) | (548.92M) | [{"date":"2019-12-31","value":-13269400000,"profit":false},{"date":"2020-12-31","value":-41825900000,"profit":false},{"date":"2021-12-31","value":-174375100000,"profit":false},{"date":"2022-12-31","value":-65793900000,"profit":false},{"date":"2023-12-31","value":-54892200000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (130.10M) | (427.50M) | (1.74B) | (657.94M) | (545.06M) | [{"date":"2019-12-31","value":-13010200000,"profit":false},{"date":"2020-12-31","value":-42750500000,"profit":false},{"date":"2021-12-31","value":-174375100000,"profit":false},{"date":"2022-12-31","value":-65793900000,"profit":false},{"date":"2023-12-31","value":-54506200000,"profit":false}] |
EPS (Diluted) | (6.13) | (6.79) | (23.29) | (8.40) | (5.53) | [{"date":"2019-12-31","value":-613,"profit":false},{"date":"2020-12-31","value":-679,"profit":false},{"date":"2021-12-31","value":-2329,"profit":false},{"date":"2022-12-31","value":-840,"profit":false},{"date":"2023-12-31","value":-553,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
NVAX | |
---|---|
Cash Ratio | 0.77 |
Current Ratio | 0.93 |
Quick Ratio | 0.93 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
NVAX | |
---|---|
ROA (LTM) | -10.76% |
ROE (LTM) | -898.20% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
NVAX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.31 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.31 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
NVAX | |
---|---|
Trailing PE | NM |
Forward PE | 8.55 |
P/S (TTM) | 1.59 |
P/B | 49.52 |
Price/FCF | NM |
EV/R | 0.92 |
EV/Ebitda | NM |
PEG | NM |
Novavax Inc (NVAX) share price today is $8.82
Yes, Indians can buy shares of Novavax Inc (NVAX) on Vested. To buy Novavax Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NVAX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Novavax Inc (NVAX) via the Vested app. You can start investing in Novavax Inc (NVAX) with a minimum investment of $1.
You can invest in shares of Novavax Inc (NVAX) via Vested in three simple steps:
The 52-week high price of Novavax Inc (NVAX) is $23.86. The 52-week low price of Novavax Inc (NVAX) is $3.53.
The price-to-earnings (P/E) ratio of Novavax Inc (NVAX) is
The price-to-book (P/B) ratio of Novavax Inc (NVAX) is 49.52
The dividend yield of Novavax Inc (NVAX) is 0.00%
The market capitalization of Novavax Inc (NVAX) is $1.40B
The stock symbol (or ticker) of Novavax Inc is NVAX